Finance

Lists
7733:TYO
Olympus Corp
1 955,00 JP¥
-0,15%
(-3,00) 1D
5-окт., 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 7733...
Open
1 973 JP¥
High
1 978 JP¥
Low
1 941 JP¥
Mkt. cap
2,18 трлн
Avg. vol.
4,33 млн
Volume
4,29 млн
Dividend
1,53%
Quarterly dividend
7 JP¥
Ex-dividend date
2024-ж., 28-мар.
P/E ratio
27,46
52-wk high
2 210 JP¥
52-wk low
1 302 JP¥
EPS
71 JP¥
Shares outstanding
341,42 млн
No. of employees
28 миң
Open
1 973 JP¥
High
1 978 JP¥
Low
1 941 JP¥
Mkt. cap
2,18 трлн
Avg. vol.
4,33 млн
Volume
4,29 млн
Dividend
1,53%
Quarterly dividend
7 JP¥
Ex-dividend date
2024-ж., 28-мар.
P/E ratio
27,46
52-wk high
2 210 JP¥
52-wk low
1 302 JP¥
EPS
71 JP¥
Shares outstanding
341,42 млн
No. of employees
28 миң
News stories
From web sources and news partners
Profile
Olympus Corporation is a Japanese manufacturer of optics and reprography products, headquartered in Hachioji, Tokyo. Olympus was founded on October 12, 1919 as Takachiho Seisakusho by Takeshi Yamashita, initially specializing in microscopes and thermometers, and later in imaging. In 1921, the name Olympus was registered as a trademark. In 1942, the company was renamed Takachiho Optical Industries, and in 1949 it was renamed Olympus Optical Co., Ltd. In 2003, the company adopted its current name, Olympus Corporation. Olympus holds roughly a 70 percent share of the global endoscope market, estimated to be worth approximately US$2.5 billion. As of 2025, endoscopes and related surgical technologies are now Olympus's exclusive product line. It was formerly also a maker of cameras, camera lenses and dictaphones, until it divested this part to OM Digital Solutions in 2020. It divested from its microscopy and scientific imaging division in 2023, selling it to Bain Capital for approximately $3.1 billion; the division operates as Evident Corporation. Wikipedia
About Olympus Corp
CEOYasuo Takeuchi
Employees28,1 миң
Founded1919-ж., 12-окт.
Headquarters-
SectorMedical device
Last report
2026-ж., 7-авг.
Fiscal period
Q1 2027
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
240,40 млд / 228,33 млд
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
247,84 млд
261,04 млд
295,28 млд
240,40 млд
Cost of goods sold
86,54 млд
96,15 млд
102,52 млд
83,57 млд
Cost of revenue
86,54 млд
96,15 млд
102,52 млд
83,57 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
119,90 млд
125,65 млд
104,14 млд
125,03 млд
Operating expense
127,74 млд
140,86 млд
145,88 млд
126,76 млд
Total operating expenses
214,27 млд
237,01 млд
248,41 млд
210,33 млд
Operating income
33,56 млд
24,04 млд
46,88 млд
30,07 млд
Other non operating income
-
-
-819,00 млн
-
EBT including unusual items
27,90 млд
22,13 млд
27,08 млд
27,56 млд
EBT excluding unusual items
27,90 млд
22,13 млд
47,09 млд
27,56 млд
Income tax expense
7,70 млд
7,96 млд
2,26 млд
8,46 млд
Effective tax rate
27,61%
35,98%
8,36%
30,69%
Other operating expenses
7,83 млд
15,21 млд
6,54 млд
1,72 млд
Net income
20,20 млд
14,17 млд
24,82 млд
19,10 млд
Net profit margin
8,15%
5,43%
8,40%
7,95%
Earnings per share
-
-
-
-
Interest and investment income
3,64 млд
356,00 млн
3,96 млд
1,43 млд
Interest expense
-5,28 млд
-2,34 млд
-2,92 млд
-2,82 млд
Net interest expenses
-1,64 млд
-1,99 млд
1,04 млд
-1,39 млд
Depreciation and amortization charges
-
-
35,20 млд
-
EBITDA
50,30 млд
41,76 млд
63,42 млд
47,38 млд
Gain or loss from assets sale
-
-
12,08 млд
-
AI content may include mistakes. Learn more
Google колдонмолору